The table below shows BIOMARIN PHARMACEUTICAL INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$3.22B
$2.85B
$2.42B
$2.10B
$1.85B
$1.86B
Cost of revenue
$717.44M
$580.24M
$532.06M
$503.02M
$470.51M
$524.27M
Gross profit
-
-
-
-
-
-
R&D
$921.93M
$747.18M
$746.77M
$649.61M
$628.79M
$628.12M
SG&A
BMRN annual revenue (10-K history)
BIOMARIN PHARMACEUTICAL INC reported annual revenue of $3.22B for fiscal year 2025. That is up 12.9% from $2.85B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.12B (FY 2016) to $3.22B. Figures come from the company's audited annual reports as filed with the SEC.
